Leadership

  • Hideki Kuki

    President

    Hideki Kuki

    President

    Hideki Kuki has been the President of Mitsubishi Tanabe Pharma Development America, Inc. since October 2016. With more than 20 years of experiences, he has held senior positions including General Manager of Project Management, Clinical Science, and Global Development Operations at our parent company, Mitsubishi Tanabe Pharma Corporation, in Japan and our group companies in Europe. He has successfully led Integrated Development Teams for canagliflozin (INVOKANA®/CANAGLU®) and other products, from the earliest development stage through NDA regulatory approval.

  • Wesley Day, Ph.D

    Vice President and Head of Clinical Development

    Wesley Day, Ph.D

    Vice President and Head of Clinical Development

    Wes has more than 20 years of experience leading global clinical and regulatory strategy and operations at all stages, from discovery through NDA/MAA approval, label expansion, and commercialization. Before joining our organization, he held senior management positions at VIVUS and Pfizer. He was also an Adjunct Associate Professor in the School of Pharmacy at the University of Maryland, Baltimore, where he earned his doctorate degree.

  • Douglas Dobak

    Vice President and Head of Regulatory Affairs

    Douglas Dobak

    Vice President and Head of Regulatory Affairs

    Doug Dobak brings extensive experience to our organization in regulatory affairs for pharmaceuticals and biologics in multiple therapeutic areas. He previously served as Global VP of Regulatory Affairs at Teva Pharmaceuticals Innovative Products. He also held senior management positions in Regulatory Affairs at NPS Pharmaceuticals, AstraZeneca, Astra Merck and Janssen Pharmaceutica.

  • Ming Ji, MD, MS

    Vice President and Head of Drug Safety

    Ming Ji, MD, MS

    Vice President and Head of Drug Safety

    For more than 18 years, Ming has worked in clinical development and drug safety for pharmaceutical companies such as Wyeth, Amgen, TAP, and AbbVie. He has strong, diverse, global safety expertise and experience, encompassing Phase I trials, complete Life Cycle Management, and leadership of multiple product safety teams. Over the past two decades, Ming has published extensively in highly respected journals.

  • Deborah L. Moorer

    Head of Human Resources and General Affairs

    Deborah L. Moorer

    Head of Human Resources and General Affairs

    In her role as Head of Human Resources (HR), Deborah Moorer oversees the strategic direction of all aspects of HR and is instrumental in shaping the company’s culture and employee development. She brings more than 20 years of HR experience to the role. Prior to joining Mitsubishi Tanabe Pharma Development America, Inc., she was Vice President of HR at Ipsen Biopharmaceuticals, Senior Vice President and HR Advisor at Citibank, and Vice President of HR at Alpharma.

  • Joseph M. Palumbo, MD

    Vice President and Head of Translational Research and Medical Science

    Joseph M. Palumbo, MD

    Vice President and Head of Translational Research and Medical Science

    Dr. Joseph Palumbo is a science-driven researcher with both clinical and pre-clinical research experience. He has held faculty positions at Yale, Cornell University, and the University of Pennsylvania. He also has held industry positions with Johnson & Johnson, Janssen Pharmaceutica, Sanofi, and Cephalon. Dr. Palumbo earned his medical degrees from The George Washington University School of Medicine and Health Sciences and from Yale University School of Medicine.